Swallowing study using water-soluble contrast agents may increase aspiration sensitivity and antedate oral feeding without respiratory and drug complications: A STROBE-compliant prospective, observational, case-control trial

Chang Ho Hwang, Chang Ho Hwang

Abstract

Although the modified barium swallowing study (MBSS) is considered the gold standard for assessing aspiration risk, aspiration of lipid-soluble barium can cause chemical pneumonitis or impair radiologic interpretation of the lungs. Water-soluble contrast agents (WSCAs) may avoid these complications while maintaining sensitivity on aspiration. This prospective, observational, case-control cohort trial evaluated all patients >3 years old referred for swallowing study from September 2015 to November 2017. Repeat evaluations of individuals were excluded. High-risk patients were evaluated by WSCA (iohexol)-based swallowing study (WSS) and others by MBSS. The study included 829 evaluations of 762 patients. After excluding 74 evaluations, 365 WSSs and 390 MBSSs were performed. The most frequent underlying condition was brain lesion, followed by aspiration pneumonia. Aspiration occurred more frequently in WSS (147 patients: 40.3%) than in MBSS (36 patients: 9.2%) (P = .00). However, neither aspiration volume (6.72 cc [3.09-10.35] vs 5.53 cc [2.21-8.85]) nor radiographic alterations differed between the 2 groups (P > .05). Moreover, the swallowed (16.62 cc [8.45-24.79]) and aspirated amounts of iohexol were not correlated with radiologic changes or deterioration (P > .05). Switching to oral feeding following WSS was more frequent (164 patients: 44.9%), whereas aspiration pneumonia was not (P = .00). WSS did not prolong the interval to patient discharge (P = .06) or induce an allergic reaction or chemotoxicity over 1 week. The absence of aspiration-induced complications and adverse drug effects suggests that, compared with MBSS, WSS may increase aspiration sensitivity and early switching to oral feeding.

Trial registration: ClinicalTrials.gov NCT03598491.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Figures

Figure 1.
Figure 1.
Flow diagram. MBSS = modified barium swallowing study, WSS = water-soluble contrast agent-based swallowing study.

References

    1. DiBardino DM, Wunderink RG. Aspiration pneumonia: a review of modern trends. J Crit Care. 2015;30:40–8.
    1. Kendall KA. Evaluation of airway protection: quantitative timing measures versus penetration/aspiration score. Laryngoscope. 2017;127:2314–8.
    1. Purkey MT, Levine MS, Prendes B, et al. . Predictors of aspiration pneumonia following radiotherapy for head and neck cancer. Ann Otol Rhinol Laryngol. 2009;118:811–6.
    1. Martin-Harris B, Brodsky MB, Michel Y, et al. . MBS measurement tool for swallow impairment--MBSImp: establishing a standard. Dysphagia. 2008;23:392–405.
    1. Kuhlemeier KV, Yates P, Palmer JB. Intra- and interrater variation in the evaluation of videofluorographic swallowing studies. Dysphagia. 1998;13:142–7.
    1. Lareau DG, Berta JW. Fatal aspiration of thick barium. Radiology. 1976;120:317–317.
    1. Franquet T, Gimenez A, Roson N, et al. . Aspiration diseases: findings, pitfalls, and differential diagnosis. Radiographics. 2000;20:673–85.
    1. Harris JA, Bartelt D, Campion M, et al. . The use of low-osmolar water-soluble contrast in videofluoroscopic swallowing exams. Dysphagia. 2013;28:520–7.
    1. Tamm I, Kortsik C. Severe barium sulfate aspirationinto the lung: clinical presentation, prognosis and therapy. Respiration. 1999;66:81–4.
    1. Voloudaki A, Ergazakis N, Gourtsoyiannis N. Late changes in barium sulfate aspiration: HRCT features. Eur Radiol. 2003;13:2226–9.
    1. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology. 1997;203:605–10.
    1. Marzella L. Center for drug evaluation and research. 2015. Available at: .
    1. Brick SH, Caroline DF, Lev-Toaff AS, et al. . Esophageal disruption: evaluation with iohexol esophagography. Radiology. 1988;169:141–3.
    1. Swanson JO, Levine MS, Redfern RO, et al. . Usefulness of high-density barium for detection of leaks after esophagogastrectomy, total gastrectomy, and total laryngectomy. AJR Am J Roentgenol. 2003;181:415–20.
    1. Auffermann W, Geisel T, Wohltmann D, et al. . Tissue reaction following endobronchial application of iopamidol and ioxithalamate in rats. Eur J Radiol. 1988;8:13–7.
    1. Davenport D, Cohen MD, Hanna MP, et al. . Studies of iodixanol in the rabbit lung and peritoneum. Pediatr Radiol. 1999;29:724–30.
    1. Ginai AZ, Bubberman A, Zondervan PE, et al. . The histological response of the lungs of rats to potentially suitable water soluble bronchographic contrast agents iotrolan (a non-ionic dimer) and iopamidol (a non-ionic monomer). Br J Radiol. 1993;66:773–7.
    1. Wells HD, Hyrnchak MA, Burbridge BE. Direct effects of contrast media on rat lungs. Can Assoc Radiol J. 1991;42:261–4.
    1. Healthcare G. Iohexol package insert. In: , ed. ; 2017. Available at: . Database Provider: GE Healthcare.
    1. Li M, Brasseur JG, Kern MK, et al. . Viscosity measurements of barium sulfate mixtures for use in motility studies of the pharynx and esophagus. Dysphagia. 1992;7:17–30.
    1. Son DS, Seong JW, Kim Y, et al. . The effects of removable denture on swallowing. Ann Rehabil Med. 2013;37:247–53.
    1. Katayama H, Spinazzi A, Fouillet X, et al. . Iomeprol: current and future profile of a radiocontrast agent. Invest Radiol. 2001;36:87–96.
    1. Rosenbek JC, Robbins JA, Roecker EB, et al. . A penetration-aspiration scale. Dysphagia. 1996;11:93–8.
    1. Logemann JA. Manual for the Videofluoroscopic Study of Swallowing. 2nd ed. Austin: Singular Pub Group; 1993XXX.
    1. Foley MJ, Ghahremani GG, Rogers LF. Reappraisal of contrast media used to detect upper gastrointestinal perforations: comparison of ionic water-soluble media with barium sulfate. Radiology. 1982;144:231–7.
    1. Keberle M, Wittenberg G, Trusen A, et al. . Comparison of iodinated and barium-containing contrast media of different viscosity in the detection of pharyngeal perforation. RoFo Fortschr Geb Rontgenstr Nuklearmed. 2001;173:691–5.
    1. Paciaroni M, Mazzotta G, Corea F, et al. . Dysphagia following stroke. Eur Neurol. 2004;51:162–7.
    1. Rofes L, Arreola V, Clave P. The volume-viscosity swallow test for clinical screening of dysphagia and aspiration. Nestle Nutr Inst Workshop Ser. 2012;72:33–42.
    1. Eibling DE, Gross RD. Subglottic air pressure: a key component of swallowing efficiency. Ann Otol Rhinol Laryngol. 1996;105:253–8.
    1. Lapi F, Cecchi E, Pedone C, et al. . Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals. Eur J Clin Pharmacol. 2008;64:723–37.
    1. Healthcare G. Warning: risks with inadvertent intrathecal administration. Food and Drug Administration. 2018. Available at: . Database Provider: GE Healthcare.
    1. Ozaki K, Kagaya H, Yokoyama M, et al. . The risk of penetration or aspiration during videofluoroscopic examination of swallowing varies depending on food types. Tohoku J Exp Med. 2010;220:41–6.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera